Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours). Elaine Sarkin Jaffe

Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)


Pathology.and.Genetics.Tumours.of.Haematopoietic.and.Lymphoid.Tissues.pdf
ISBN: 9283224116,9789283224112 | 352 pages | 9 Mb


Download Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)



Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours) Elaine Sarkin Jaffe
Publisher:




EKLF mRNA expression is correlated with expression .. Harris NL JE, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. Comprehensive Geriatric Oncology. Lyon, France: International Agency for Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lyon, France: IARC Press; 2001. The initial differential diagnosis WHO classification of tumours of hematopoietic and lymphoid tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): World health organization classification of tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. As with virtually all WHO lymphoid neoplasms, the diagnosis of SMZL is based on elements of morphology (including peripheral blood villous lymphocytes when present), immunophenotype, and genetic information. EKLF has surprisingly been associated with tumors such as cancer in the endometrial epithelial cells, and is increased by treatment with tamoxifen or oestrogen [27].